Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05210322 · ClinicalTrials.gov registry record
Percutaneous Cholangiopancreatoscopy Registry
A clinical trial of Biliary Stricture and Cholangiocarcinoma, Intrahepatic, sponsored by Johns Hopkins University.
- Active
- Registry status
- 679
- Enrollment target
- 1
- Study location
NCT05210322: Active study of Biliary Stricture and Cholangiocarcinoma, Intrahepatic, sponsored by Johns Hopkins University.
NCT05210322 is a study of Biliary Stricture and Cholangiocarcinoma, Intrahepatic that is active but no longer recruiting, run by Johns Hopkins University. The registered enrollment target is 679 participants, above the 43-participant average among 3 other Biliary Stricture trials with a reported enrollment target (1479% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05210322, a study of Biliary Stricture and Cholangiocarcinoma, Intrahepatic, is active but no longer recruiting, sponsored by Johns Hopkins University.
- ACTIVE NOT RECRUITING
- Registry status
- 679 participants
- Enrollment target
- 1
- Study location
Study Summary
The Percutaneous Cholangiopancreatoscopy (PCPS) registry is an observational, multicentric, prospective, and retrospective registry of patients undergoing the percutaneous cholangiopancreatoscopy procedure at sites across the United States. In the retrospective component of the study, clinical and procedural data regarding patients who have undergone clinical indicated percutaneous cholangiopancreatoscopy procedure in the past will be collected from all the registry sites and stored in a secure database. The prospective component of the registry will run for three years at each site where patients undergoing the clinically indicated percutaneous cholangiopancreatoscopy procedure will be enrolled in the study, and the patients' data will be collected whenever the patients present to interventional radiology (IR) for a procedure or clinic visit.
Primary Outcome
Tube free survival will be calculated by estimating the number of patients who can undergo removal of the biliary/ cholecystostomy tube after the PCPS procedure until their last IR clinical follow-up or death.
Conditions Studied
Interventions
- PROCEDURE Percutaneous cholangiopancreatoscopy
Study Locations (1)
Maryland
- Johns Hopkins Hospital - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 679 participants |
| Start Date | 2022-01-01 |
| Est. Completion | 2027-06-30 |
What the registry record for NCT05210322 still lists
NCT05210322 is an observational study that tracks outcomes without assigning an intervention. The registered 679 participants enrollment target is mid-sized for trials with a published cap, above the 43-participant average among 3 other Biliary Stricture trials with a reported enrollment target (1479% higher).
The record links to 5 conditions, with Biliary Stricture appearing as the primary indexed condition, and to 1 intervention - of which Percutaneous cholangiopancreatoscopy is the first listed.
NCT05210322 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT05210322 about?
NCT05210322 is a clinical study titled "Percutaneous Cholangiopancreatoscopy Registry". The Percutaneous Cholangiopancreatoscopy (PCPS) registry is an observational, multicentric, prospective, and retrospective registry of patients undergoing the percutaneous cholangiopancreatoscopy procedure at sites across the United States. In the retrospective component of the study, clinical and p...
What is the current status of trial NCT05210322?
This trial is currently active not recruiting. The enrollment target is 679 participants. The study started on 2022-01-01. Estimated completion is 2027-06-30.
What conditions does trial NCT05210322 study?
This clinical trial studies the following conditions: Biliary Stricture, Cholangiocarcinoma, Intrahepatic, Cholelithiasis, Choledocholithiasis, Biliary Stones.
What interventions are being tested in trial NCT05210322?
The interventions under investigation include: Percutaneous cholangiopancreatoscopy (PROCEDURE).
Who is sponsoring clinical trial NCT05210322?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05210322 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Biliary Stricture
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03501706 · 680 participants · NA
An Assessment of Cognitive Improvement Training Among Mid-life Individuals
- NCT05626452 · 680 participants · NA
PrEP Optimization Among Women to Enhance Retention and Uptake
- NCT05753748 · 680 participants · NA
Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia
- NCT05952141 · 680 participants · NA
Strategies to Close the Gap From Cervical Cancer Diagnosis to Treatment in Botswana
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI